ARTBIO Strengthens Nuclear Metrology Expertise With Senior Leadership Hire

According to a recent LinkedIn post from ARTBIO, the company is adding Denis Bergeron as Senior Director of Nuclear Metrology to support its alpha radioligand therapy clinical programs. The post notes that Bergeron previously spent 18 years in the Radioactivity Group at the National Institute of Standards and Technology and has held editorial and professional roles in nuclear medicine organizations.

For investors, the hire suggests ARTBIO is deepening its in‑house expertise in measurement science and standards, which are critical for the development and regulatory validation of radiopharmaceuticals. Strengthening this capability could enhance the robustness of ARTBIO’s clinical data packages and potentially improve its positioning in the competitive alpha radioligand therapy space.